Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof

Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof

US Patent 10577415 · Granted Mar 3, 2020

Estimated economic value: $711,570,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Picture frame2024
IgG bispecific antibodies and processes for preparation2024
Bispecific antibodies targeting immune checkpoints2024
Methods for producing fabs and IgG bispecific antibodies2023
CD200R agonist antibodies and uses thereof2022
CD200R agonist antibodies and uses thereof2022
DNA molecules encoding anti-IL-33 antibodies2021
IgG bispecific antibodies and processes for preparation2020
Methods for producing Fabs and bi-specific antibodies2020
Methods for producing Fabs and bi-specific antibodies2020
Anti-IL-33 antibodies and uses thereof for disease treatment2019
Methods for producing fabs and bi-specific antibodies2019